LSL PHARMA DISTRIBUTION

Serial Number 79382396
Registration 7699739
700

Registration Progress

Application Filed
May 24, 2023
Under Examination
Approved for Publication
Jan 7, 2025
Published for Opposition
Jan 7, 2025
Registered
Feb 25, 2025

Trademark Image

LSL PHARMA DISTRIBUTION

Basic Information

Serial Number
79382396
Registration Number
7699739
Filing Date
May 24, 2023
Registration Date
February 25, 2025
Published for Opposition
January 7, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 25, 2025
Registration
Registered
Classes
035 039

Rights Holder

R.G.C.C. Holdings AG

25
Address
Baarerstrasse 95
CH-6300 Zug
CH

Ownership History

R.G.C.C. Holdings AG

Original Applicant
25
CH

R.G.C.C. Holdings AG

Owner at Publication
25
CH

R.G.C.C. Holdings AG

Original Registrant
25
CH

Legal Representation

Attorney
James R. Menker

USPTO Deadlines

Next Deadline
1863 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20250225)
Due Date
February 25, 2031
Grace Period Ends
August 25, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Oct 3, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Sep 11, 2025 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Sep 11, 2025 FIMP P FINAL DISPOSITION PROCESSED Loading...
May 25, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Apr 19, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Mar 31, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Mar 31, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Feb 25, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 25, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 7, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 7, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 1, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 10, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 21, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 21, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 21, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 21, 2024 PETG O PETITION TO REVIVE-GRANTED Loading...
Oct 21, 2024 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Apr 30, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Apr 6, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Apr 6, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 19, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 18, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 14, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 7, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 3, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 2, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 035
Advertising services; commercial business management; commercial administration of the licensing of the goods and services of others; Providing office functions
Class 039
Transport, in particular delivery of medicines in the framework of a mail-order pharmacy and in the framework of a pharmaceutical wholesale trade; packaging and storage of merchandise for others

Additional Information

Design Mark
The mark consists of the blue wording "LSL", a blue shield with a white cross, and the wording "PHARMA DISTRIBUTION" in light gray.
Color Claim
The color(s) blue, light gray and white is/are claimed as a feature of the mark.

Classification

International Classes
035 039

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA DISTRIBUTION"